July 26, 2018
GenSight Biologics Reports Interim Financial Results for the First Half of 2018
Media
July 24, 2018
Q2 2018 Interim Report – invitation to conference call and webcast
July 24, 2018
Q2 2018 General Market Overview
July 18, 2018
BONESUPPORT appoints Michael Diefenbeck as Head of Research & Development, Medical and Clinical Affairs
July 18, 2018
Cash position and activity update for H1 2018 and key perspectives for the end of 2018
July 13, 2018
HealthCap makes 112th investment as Swedish company Modus Therapeutics completes SEK 140 million financing led by HealthCap
July 12, 2018
Altimmune Restructures Financing Agreement with Majority of the Remaining Series B Investors
July 12, 2018
Targovax and SOTIO announce first patient dosed in Phase I/II combination trial of ONCOS-102 with DCVAC
July 12, 2018
New Preclinical Results on Onxeo’s AsiDNA™, First-in-Class DNA Repair Inhibitor, Point to Strong Synergy and Reversion of Tumor Resistance when combined to PARP inhibitors
July 12, 2018
Interim Report Q2 2018